Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer

Helena Pópulo, Bruno Nunes, Cristina Sampaio, Rui Batista, Marta Teixeira Pinto, Tiago B. Gaspar, Leandro Miranda-Alves, Ren Zhi Cai, Xian Yang Zhang, Andrew V Schally, Manuel Sobrinho-Simões, Paula Soares

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Growth hormone-releasing hormone (GHRH) is a peptide hormone secreted by the hypothalamus that regulates the synthesis and secretion of growth hormone (GH) in the pituitary. The extra-hypothalamic GHRH and its cognate receptors (GHRHR and splice variants) play a mitogenic role by stimulating cell proliferation and preventing apoptotic cell death. It is well established that GHRH antagonists inhibit the growth, tumorigenicity, and metastasis of various human malignancies. In this work, we studied the effect of two new GHRH antagonists, MIA602 and MIA690, on thyroid cancer. We studied the effect of MIA602 and MIA690 on thyroid cancer in vitro, using human thyroid cancer cell lines, and in vivo, using chicken embryo chorioallantoic membrane (CAM) assays. We found that mRNA for GHRH and GHRH receptor is expressed in thyroid cell lines and in samples of thyroid tumors. Immunohistochemistry confirmed the expression of GHRHR protein in specimens of thyroid tumor. We observed that GHRH antagonists inhibited the growth and increased apoptosis of thyroid cancer cells. In vivo, the antagonists inhibited growth and angiogenesis of engrafted thyroid tumors. Our results suggest that GHRH expression may play a role in growth of thyroid cancer and that GHRH antagonists can be a therapeutic option for thyroid cancer patients.

Original languageEnglish (US)
Pages (from-to)314-324
Number of pages11
JournalHormones and Cancer
Volume8
Issue number5-6
DOIs
StatePublished - Dec 1 2017

Fingerprint

Growth Hormone-Releasing Hormone
Thyroid Neoplasms
Hormone Antagonists
Thyroid Gland
Growth
Neoplasms
Hypothalamic Hormones
Chorioallantoic Membrane
Cell Line
Peptide Hormones
Growth Hormone
Hypothalamus
Chickens
Cell Death
Embryonic Structures
Immunohistochemistry
Cell Proliferation
Apoptosis
Neoplasm Metastasis
Messenger RNA

Keywords

  • GHRH antagonists
  • Growth hormone-releasing hormone
  • Hypothalamic hormone
  • mRNA for GHRH
  • mRNA for GHRH receptors
  • Thyroid cancer

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Cancer Research

Cite this

Pópulo, H., Nunes, B., Sampaio, C., Batista, R., Pinto, M. T., Gaspar, T. B., ... Soares, P. (2017). Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer. Hormones and Cancer, 8(5-6), 314-324. https://doi.org/10.1007/s12672-017-0307-4

Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer. / Pópulo, Helena; Nunes, Bruno; Sampaio, Cristina; Batista, Rui; Pinto, Marta Teixeira; Gaspar, Tiago B.; Miranda-Alves, Leandro; Cai, Ren Zhi; Zhang, Xian Yang; Schally, Andrew V; Sobrinho-Simões, Manuel; Soares, Paula.

In: Hormones and Cancer, Vol. 8, No. 5-6, 01.12.2017, p. 314-324.

Research output: Contribution to journalArticle

Pópulo, H, Nunes, B, Sampaio, C, Batista, R, Pinto, MT, Gaspar, TB, Miranda-Alves, L, Cai, RZ, Zhang, XY, Schally, AV, Sobrinho-Simões, M & Soares, P 2017, 'Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer', Hormones and Cancer, vol. 8, no. 5-6, pp. 314-324. https://doi.org/10.1007/s12672-017-0307-4
Pópulo, Helena ; Nunes, Bruno ; Sampaio, Cristina ; Batista, Rui ; Pinto, Marta Teixeira ; Gaspar, Tiago B. ; Miranda-Alves, Leandro ; Cai, Ren Zhi ; Zhang, Xian Yang ; Schally, Andrew V ; Sobrinho-Simões, Manuel ; Soares, Paula. / Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer. In: Hormones and Cancer. 2017 ; Vol. 8, No. 5-6. pp. 314-324.
@article{416e85ccd9bc47c083b637972184f2d7,
title = "Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer",
abstract = "Growth hormone-releasing hormone (GHRH) is a peptide hormone secreted by the hypothalamus that regulates the synthesis and secretion of growth hormone (GH) in the pituitary. The extra-hypothalamic GHRH and its cognate receptors (GHRHR and splice variants) play a mitogenic role by stimulating cell proliferation and preventing apoptotic cell death. It is well established that GHRH antagonists inhibit the growth, tumorigenicity, and metastasis of various human malignancies. In this work, we studied the effect of two new GHRH antagonists, MIA602 and MIA690, on thyroid cancer. We studied the effect of MIA602 and MIA690 on thyroid cancer in vitro, using human thyroid cancer cell lines, and in vivo, using chicken embryo chorioallantoic membrane (CAM) assays. We found that mRNA for GHRH and GHRH receptor is expressed in thyroid cell lines and in samples of thyroid tumors. Immunohistochemistry confirmed the expression of GHRHR protein in specimens of thyroid tumor. We observed that GHRH antagonists inhibited the growth and increased apoptosis of thyroid cancer cells. In vivo, the antagonists inhibited growth and angiogenesis of engrafted thyroid tumors. Our results suggest that GHRH expression may play a role in growth of thyroid cancer and that GHRH antagonists can be a therapeutic option for thyroid cancer patients.",
keywords = "GHRH antagonists, Growth hormone-releasing hormone, Hypothalamic hormone, mRNA for GHRH, mRNA for GHRH receptors, Thyroid cancer",
author = "Helena P{\'o}pulo and Bruno Nunes and Cristina Sampaio and Rui Batista and Pinto, {Marta Teixeira} and Gaspar, {Tiago B.} and Leandro Miranda-Alves and Cai, {Ren Zhi} and Zhang, {Xian Yang} and Schally, {Andrew V} and Manuel Sobrinho-Sim{\~o}es and Paula Soares",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s12672-017-0307-4",
language = "English (US)",
volume = "8",
pages = "314--324",
journal = "Hormones and Cancer",
issn = "1868-8497",
publisher = "Springer US",
number = "5-6",

}

TY - JOUR

T1 - Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer

AU - Pópulo, Helena

AU - Nunes, Bruno

AU - Sampaio, Cristina

AU - Batista, Rui

AU - Pinto, Marta Teixeira

AU - Gaspar, Tiago B.

AU - Miranda-Alves, Leandro

AU - Cai, Ren Zhi

AU - Zhang, Xian Yang

AU - Schally, Andrew V

AU - Sobrinho-Simões, Manuel

AU - Soares, Paula

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Growth hormone-releasing hormone (GHRH) is a peptide hormone secreted by the hypothalamus that regulates the synthesis and secretion of growth hormone (GH) in the pituitary. The extra-hypothalamic GHRH and its cognate receptors (GHRHR and splice variants) play a mitogenic role by stimulating cell proliferation and preventing apoptotic cell death. It is well established that GHRH antagonists inhibit the growth, tumorigenicity, and metastasis of various human malignancies. In this work, we studied the effect of two new GHRH antagonists, MIA602 and MIA690, on thyroid cancer. We studied the effect of MIA602 and MIA690 on thyroid cancer in vitro, using human thyroid cancer cell lines, and in vivo, using chicken embryo chorioallantoic membrane (CAM) assays. We found that mRNA for GHRH and GHRH receptor is expressed in thyroid cell lines and in samples of thyroid tumors. Immunohistochemistry confirmed the expression of GHRHR protein in specimens of thyroid tumor. We observed that GHRH antagonists inhibited the growth and increased apoptosis of thyroid cancer cells. In vivo, the antagonists inhibited growth and angiogenesis of engrafted thyroid tumors. Our results suggest that GHRH expression may play a role in growth of thyroid cancer and that GHRH antagonists can be a therapeutic option for thyroid cancer patients.

AB - Growth hormone-releasing hormone (GHRH) is a peptide hormone secreted by the hypothalamus that regulates the synthesis and secretion of growth hormone (GH) in the pituitary. The extra-hypothalamic GHRH and its cognate receptors (GHRHR and splice variants) play a mitogenic role by stimulating cell proliferation and preventing apoptotic cell death. It is well established that GHRH antagonists inhibit the growth, tumorigenicity, and metastasis of various human malignancies. In this work, we studied the effect of two new GHRH antagonists, MIA602 and MIA690, on thyroid cancer. We studied the effect of MIA602 and MIA690 on thyroid cancer in vitro, using human thyroid cancer cell lines, and in vivo, using chicken embryo chorioallantoic membrane (CAM) assays. We found that mRNA for GHRH and GHRH receptor is expressed in thyroid cell lines and in samples of thyroid tumors. Immunohistochemistry confirmed the expression of GHRHR protein in specimens of thyroid tumor. We observed that GHRH antagonists inhibited the growth and increased apoptosis of thyroid cancer cells. In vivo, the antagonists inhibited growth and angiogenesis of engrafted thyroid tumors. Our results suggest that GHRH expression may play a role in growth of thyroid cancer and that GHRH antagonists can be a therapeutic option for thyroid cancer patients.

KW - GHRH antagonists

KW - Growth hormone-releasing hormone

KW - Hypothalamic hormone

KW - mRNA for GHRH

KW - mRNA for GHRH receptors

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=85029580437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029580437&partnerID=8YFLogxK

U2 - 10.1007/s12672-017-0307-4

DO - 10.1007/s12672-017-0307-4

M3 - Article

VL - 8

SP - 314

EP - 324

JO - Hormones and Cancer

JF - Hormones and Cancer

SN - 1868-8497

IS - 5-6

ER -